{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:21:01Z","timestamp":1791091261561,"version":"4.1.0"},"reference-count":30,"publisher":"Europa Digital & Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.4244\/eijv10i2a34","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T05:51:50Z","timestamp":1405662710000},"page":"204-211","source":"Crossref","is-referenced-by-count":16,"title":["Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial"],"prefix":"10.4244","volume":"10","author":[{"given":"Victor","family":"Legrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathy","family":"Vrolix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Dens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-201461418408-0","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.","volume":"56","author":"Bonello L","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.","volume":"58","author":"Brar SS","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-2","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.","volume":"363","author":"Mehta SR","year":"2010","journal-title":"N Engl J Med."},{"key":"key-201461418408-3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin L","year":"2009","journal-title":"N Engl J Med."},{"key":"key-201461418408-4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott SD","year":"2007","journal-title":"N Engl J Med."},{"key":"key-201461418408-5","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.105.559088","article-title":"Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE Trial.","volume":"112","author":"Von Beckerath N","year":"2005","journal-title":"Circulation."},{"key":"key-201461418408-6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.amjcard.2010.06.044","article-title":"Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.","volume":"106","author":"Mangiacapra F","year":"2010","journal-title":"Am J Cardiol."},{"key":"key-201461418408-7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomized factorial trial.","volume":"376","author":"Mehta SR","year":"2010","journal-title":"Lancet."},{"key":"key-201461418408-8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome P-450 polymorphisms and response to clopidogrel.","volume":"360","author":"Mega JL","year":"2009","journal-title":"N Engl J Med."},{"key":"key-201461418408-9","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.","volume":"107","author":"Gurbel PA","year":"2003","journal-title":"Circulation."},{"key":"key-201461418408-10","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","article-title":"2011 ACCF\/AHA focused update incorporated into the ACC\/AHA 2007 Guidelines for the Management of Patients with Unstable Angina\/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons.","volume":"57","author":"Wright RS","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous intervention: the GRAVITAS randomized trial.","volume":"305","author":"Price MJ","year":"2011","journal-title":"JAMA."},{"key":"key-201461418408-12","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","article-title":"A randomized trial of prasugrel versus clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.","volume":"59","author":"Trenk D","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention. A time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 Assay: Impact on the Thrombosis and Safety (GRAVITAS) trial.","volume":"124","author":"Price MJ","year":"2011","journal-title":"Circulation."},{"key":"key-201461418408-14","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet function monitoring in patients with coronary artery disease.","volume":"50","author":"Gurbel PA","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.","volume":"29","author":"Price MJ","year":"2008","journal-title":"Eur Heart J."},{"key":"key-201461418408-16","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel treatment.","volume":"43","author":"Chen WH","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jacc.2007.09.011","article-title":"Universal definition of myocardial infarction.","volume":"50","author":"Thygesen K","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-18","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE","year":"2007","journal-title":"Circulation."},{"key":"key-201461418408-19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/ccd.21345","article-title":"Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis.","volume":"71","author":"Nienhuis MB","year":"2008","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201461418408-20","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jacc.2006.06.065","article-title":"Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.","volume":"48","author":"Hochholzer W","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","article-title":"Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO study.","volume":"52","author":"Patti G","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCINTERVENTIONS.108.809285","article-title":"Stent parameters predict major adverse clinical events and the response to platelet glycoprotein IIb\/IIIa blockade: findings of the ESPRIT trial.","volume":"2","author":"Tcheng JE","year":"2009","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201461418408-23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/ccd.22962","article-title":"Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.","volume":"77","author":"Feldman DN","year":"2011","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-201461418408-24","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehi455","article-title":"Peri-procedural myocardial injury: 2005 update.","volume":"26","author":"Herrmann J.","year":"2005","journal-title":"Eur Heart J."},{"key":"key-201461418408-25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJMra0912134","article-title":"Myocardial infarction due to percutaneous coronary intervention.","volume":"364","author":"Prasad A","year":"2011","journal-title":"N Engl J Med."},{"key":"key-201461418408-26","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1161\/CIRCULATIONAHA.106.675991","article-title":"Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.","volume":"115","author":"Maree AO","year":"2007","journal-title":"Circulation."},{"key":"key-201461418408-27","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual response to clopidogrel. Clinical implication, management and future perspectives.","volume":"49","author":"Angiolillo DJ","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-28","first-page":"169","article-title":"Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading dose be weight adjusted?","volume":"16","author":"Angiolillo DJ","year":"2004","journal-title":"J Invasive Cardiol."},{"key":"key-201461418408-29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.jacc.2007.03.019","article-title":"Elevated plasma fibrinogen level predicts suboptimal response to therapy with both single- and double-bolus eptifibatide during percutaneous coronary intervention.","volume":"49","author":"Mahmud E","year":"2007","journal-title":"J Am Coll Cardiol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T20:06:43Z","timestamp":1565640403000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/73th_issue\/34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["EIJV10I2A34"],"URL":"https:\/\/doi.org\/10.4244\/eijv10i2a34","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}